Comparer des méthodes

	EORTC QLQ-C15-PAL : Qualité de vie dans les soins palliatifs en oncologie	FACT-Lung : Évaluation fonctionnelle des thérapies anticancéreuses
Domaine	Oncologie	Oncologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2006	1995
Auteur d'origine	Groenvold, M., et al. (EORTC Quality of Life Group)	David F. Cella, Ph.D.
Type	Self-report questionnaire	Self-report questionnaire
Source fondatrice	Groenvold, M., Petersen, M. A., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., et al. (2006). The development of the EORTC QLQ-C15-PAL: a shortened quality-of-life questionnaire for cancer patients in palliative care. Eur J Cancer, 42(1), 55–64.	Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153.
Alias	QLQ-C15-PAL	FACT-L
Apparentées	5	5
Résumé	The EORTC QLQ-C15-PAL is a 15-item quality-of-life instrument specifically designed for advanced cancer patients receiving palliative care. Developed by Groenvold et al. in 2006, it is a shortened version of the QLQ-C30, retaining core QoL domains while reducing respondent burden—critical in palliative settings where fatigue and functional impairment limit questionnaire completion. It measures physical, emotional, and functional well-being alongside key palliative symptoms.	The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden.